1[1]Hirsch AT.Vascular disease,hypertension and prevention:from endothelinm to clinical events.JAGG,2003,42:377-379.
2[2]Bagatcheva NV,Garcia JG,Verin AD.Molecular mechanism of rombin-induced endothelial cell permeability.Biochemistry,2002,67:75-84.
3[3]Villamor E,Kessels CG,Van Suylen RJ,et al.Cardiopulmonary effect of zdministration of the NO synthase inhibitor L-NAME in the embryo.Biol Neonate,2005,88:156-163.
4[4]Tan X,Pan JQ,Li JG,et al.L-Arginine inhibiting pulmonary vascular remodling is associatedwith promotion of apoptosis in pulmonary arterioles smooth muscle cell in broiler.Res Vet Sci,2005,79:203-209.
5[5]Smith AP,Oemoncheaux EA,Higenbottam TW.Nitric oxide gas decrease endothelin-1 mRNA in cultured pulmonary artery endothelial cell.Nitric oxide,2002,6:153-157.
6[6]Jozse FL,khreiss T,Founier A.Extracellular singnal-regulated kinase plays a essential role in endothelin-1 induced homotypicadhesion of human necctrophil granlocytes.Br J Pharmacol,2002,135:1167-1174.
7[7]Uscio LV,Barton M,Shaw S,et al.Endothelin in a theroscerosis importance rise factors and therapeutic implication.J Cardiovasc Pharamacol,2000,35:S55-S59.
9[9]Langleben D,Barst RJ,Badesch D,et al.Continuous infusion of epoprostenolimproves the net balance between pulmonary endothelin-lclearance and release in primary pulmonary hypertension.Circulation,1999,99:3266-3271.
10[10]Eddahibi S,Adont S.The serotonin pathway in pulmonary hypertension.Aach Mal Coeur Vaiss,2006,99:621-625.
5Simonnean G,Galie N,Rubin LJ,et al.Clinical classification of pulmonary hypertension.J Am Coll Cardiol,2004,43:S5-12.
6Galie N,Torbicki A,Barst R,et al.Guidelines on diagnosis and treatment of pulmonary arterial hypertension.The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.Eur Heart J,2004,25:2243-2278.
7Harch S,Whifford H,McLean C.Failure of medical therapy in pulmonary arterial hypertension.Is there an alternative diagnosis? Chost,2009,135:1462-1469.
8Simonneau G,Robbins IM,Beghetti M,et al.Updated clinical classification of pulmonary hypertension.J Am Coll Cardiol,2009,54:S43-54.
9Pietra GG,Capron F,Stewart S,et al.Pathologic assessment of vasculopathios in pulmonary hypertension.J Am Coll Cardiol,2004,43:S25-32.
